Geron GERN Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Product | ||||||
| Government rebates | -$4.26M-329% | -$2.67M-188% | -$3.22M— | -$1.44M— | -$992K— | |
| Gross product revenue | $243.15M+80.5% | $223.11M+150% | $219.25M— | $191.71M— | $134.73M— | |
| Sales returns and allowances | -$5.33M-1,476% | -$3.85M-1,611% | -$2.57M— | -$854K— | -$338K— | |
| R&D by Product | ||||||
| Chemistry, manufacturing, and control expenses | $9M-47.1% | $9.9M-62.9% | $7.4M— | $6.6M— | $17M— | |
| Research and clinical expenses | $53.5M-15.1% | $54.2M-17.5% | $64.4M— | $64.3M— | $63M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Geron break its business down?
- Geron (GERN) reports total revenues by product across 5 parts — Chargebacks, Distributor service fees, Government rebates, Gross product revenue and Sales returns and allowances. Each is extracted from the segment footnotes and tracked over time.
- Where does Geron's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Geron's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
